Literature DB >> 25202042

The intercellular cell adhesion molecule-1 (icam-1) in lung cancer: implications for disease progression and prognosis.

Elias A Kotteas1, Panagiotis Boulas1, Ioannis Gkiozos1, Sofia Tsagkouli1, George Tsoukalas1, Konstantinos N Syrigos2.   

Abstract

The intercellular cell-adhesion molecule-1 (ICAM-1) is a transmembrane molecule and a distinguished member of the Immunoglobulin superfamily of proteins that participates in many important processes, including leukocyte endothelial transmigration, cell signaling, cell-cell interaction, cell polarity and tissue stability. ICAM-1and its soluble part are highly expressed in inflammatory conditions, chronic diseases and a number of malignancies. In the present article we present the implications of ICAM-1 in the progression and prognosis of one of the major global killers of our era: lung cancer. Copyright
© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Intercellular cell-adhesion molecule; cell polarity; cell signaling; cell-cell interaction; immunoglobulin; lung cancer; prognosis; review

Mesh:

Substances:

Year:  2014        PMID: 25202042

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  37 in total

1.  Optical Imaging of Triple-Negative Breast Cancer Cells in Xenograft Athymic Mice Using an ICAM-1-Targeting Small-Molecule Probe.

Authors:  Yanqiu Zhang; Mengru Wang; Wanhua Liu; Xin Peng
Journal:  Mol Imaging Biol       Date:  2019-10       Impact factor: 3.488

2.  Expressions of TGF-β2, bFGF and ICAM-1 in lens epithelial cells of complicated cataract with silicone oil tamponade.

Authors:  Bei Liu; Jing Gao; Bo-Chang Lyu; Shan-Shuang Du; Cheng Pei; Zhong-Qiao Zhu; Bo Ma
Journal:  Int J Ophthalmol       Date:  2017-07-18       Impact factor: 1.779

Review 3.  Proteomics analysis of bodily fluids in pancreatic cancer.

Authors:  Sheng Pan; Teresa A Brentnall; Ru Chen
Journal:  Proteomics       Date:  2015-04-27       Impact factor: 3.984

4.  Hydrogen gas inhalation ameliorates lung injury after hemorrhagic shock and resuscitation.

Authors:  Duk Hwan Moon; Du-Young Kang; Seok Jin Haam; Tetsuya Yumoto; Kohei Tsukahara; Taihei Yamada; Atsunori Nakao; Sungsoo Lee
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

Review 5.  Mechanisms of Cannabidiol (CBD) in Cancer Treatment: A Review.

Authors:  Camren G Heider; Sasha A Itenberg; Jiajia Rao; Hang Ma; Xian Wu
Journal:  Biology (Basel)       Date:  2022-05-26

6.  Association of intercellular adhesion molecule-1 single nucleotide polymorphisms with hepatocellular carcinoma susceptibility and clinicopathologic development.

Authors:  Tsung-Po Chen; Hsiang-Lin Lee; Yu-Hui Huang; Ming-Ju Hsieh; Whei-Ling Chiang; Wu-Hsien Kuo; Ming-Chih Chou; Shun-Fa Yang; Chao-Bin Yeh
Journal:  Tumour Biol       Date:  2015-09-05

7.  CAR T Therapy Targeting ICAM-1 Eliminates Advanced Human Thyroid Tumors.

Authors:  Irene M Min; Enda Shevlin; Yogindra Vedvyas; Marjan Zaman; Brian Wyrwas; Theresa Scognamiglio; Maureen D Moore; Weibin Wang; Susan Park; Spencer Park; Suraj Panjwani; Katherine D Gray; Andrew B Tassler; Rasa Zarnegar; Thomas J Fahey; Moonsoo M Jin
Journal:  Clin Cancer Res       Date:  2017-10-12       Impact factor: 12.531

8.  STAT1 modification improves therapeutic effects of interferons on lung cancer cells.

Authors:  Junjie Chen; Jialu Zhao; Lefu Chen; Nian Dong; Zhaojian Ying; Zhenzhen Cai; Dongxiang Ji; Yong Zhang; Li Dong; Yuping Li; Lei Jiang; Michael J Holtzman; Chengshui Chen
Journal:  J Transl Med       Date:  2015-09-08       Impact factor: 5.531

9.  Inhibition of secretory phospholipase A2 IIa attenuates prostaglandin E2-induced invasiveness in lung adenocarcinoma.

Authors:  Alison L Halpern; Patrick D Kohtz; Jessica Y Rove; Lihua Ao; Xianzhong Meng; David A Fullerton; Michael J Weyant
Journal:  Mol Cell Biochem       Date:  2019-01-25       Impact factor: 3.396

10.  Bispecific CAR T Cells against EpCAM and Inducible ICAM-1 Overcome Antigen Heterogeneity and Generate Superior Antitumor Responses.

Authors:  Yanping Yang; Jaclyn E McCloskey; Huan Yang; Janusz Puc; Yago Alcaina; Yogindra Vedvyas; Angel A Gomez Gallegos; Elizabeth Ortiz-Sánchez; Elisa de Stanchina; Irene M Min; Eric von Hofe; Moonsoo M Jin
Journal:  Cancer Immunol Res       Date:  2021-08-02       Impact factor: 11.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.